Get the Stockscreener App
8.71
1.16%
0.10
After Hours:
8.84
0.13
+1.49%
Ginkgo Bioworks Holdings Inc stock is traded at $8.71, with a volume of 846.97K.
It is up +1.16% in the last 24 hours and down -35.81% over the past month.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
See More
Previous Close:
$8.61
Open:
$8.61
24h Volume:
846.97K
Relative Volume:
0.56
Market Cap:
$422.64M
Revenue:
$217.11M
Net Income/Loss:
$-651.19M
P/E Ratio:
-0.6705
EPS:
-12.99
Net Cash Flow:
$-387.26M
1W Performance:
+11.24%
1M Performance:
-35.81%
6M Performance:
+24.61%
1Y Performance:
+7.00%
1-Day Range:
$8.41
$8.855
1-Week Range:
$7.63
$8.855
52-Week Range:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Name
Ginkgo Bioworks Holdings Inc
Sector
Industry
Phone
(877) 442-5362
Address
27 DRYDOCK AVENUE, BOSTON
Compare DNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
8.71 | 521.68M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-24 | Downgrade | BTIG Research | Neutral → Sell |
| May-10-24 | Downgrade | William Blair | Mkt Perform → Underperform |
| Nov-14-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-09-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-02-23 | Downgrade | Goldman | Neutral → Sell |
| May-11-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-29-22 | Initiated | Berenberg | Buy |
| Oct-04-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Feb-23-22 | Initiated | Goldman | Neutral |
| Feb-01-22 | Initiated | BofA Securities | Neutral |
| Jan-28-22 | Initiated | BofA Securities | Buy |
| Jan-07-22 | Initiated | BTIG Research | Buy |
| Nov-29-21 | Initiated | Jefferies | Buy |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Oct-12-21 | Initiated | William Blair | Outperform |
| Sep-20-21 | Initiated | HSBC Securities | Buy |
View All
Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News
What analysts say about Ginkgo Bioworks Holdings Inc stockMarket Capitalization Trends & High Return Capital Strategies - earlytimes.in
(DNA) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
How Ginkgo Bioworks Holdings Inc. Class stock compares with tech leaders2025 Geopolitical Influence & AI Forecast for Swing Trade Picks - newser.com
How Ginkgo Bioworks Holdings Inc. Class stock benefits from digital adoptionStop Loss & Weekly High Potential Stock Alerts - newser.com
Will Ginkgo Bioworks (DNA) Leverage ARPA-H Partnership to Advance Its Oral Therapeutics Ambitions? - Yahoo Finance
Ginkgo Bioworks: Scaling Science, Not Revenue (NYSE:DNA) - Seeking Alpha
Is Ginkgo Bioworks Holdings Inc. Class stock resilient in recession scenarios - newser.com
Ginkgo Bioworks Holdings Inc. stock daily chart insightsJuly 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com
Can Ginkgo Bioworks Holdings Inc. stock beat market expectations this quarter - newser.com
Will Ginkgo Bioworks Holdings Inc. stock gain from lower inflationWeekly Market Summary & Real-Time Price Movement Reports - newser.com
Is it time to cut losses on Ginkgo Bioworks Holdings Inc.Trade Exit Summary & AI Based Buy and Sell Signals - newser.com
Exit strategy if you’re trapped in Ginkgo Bioworks Holdings Inc.2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
Can Ginkgo Bioworks Holdings Inc. stock surprise with earnings upsideEarnings Overview Summary & AI Powered Buy/Sell Recommendations - newser.com
Published on: 2025-11-19 04:21:37 - newser.com
Will Ginkgo Bioworks Holdings Inc. Class stock deliver compounding returnsQuarterly Risk Review & Accurate Entry and Exit Point Alerts - newser.com
Ginkgo Bioworks (DNA): Rethinking Valuation After New University Collaboration in ARPA-H MIGHTY Oral Health Initiative - Yahoo Finance
Will Ginkgo Bioworks Holdings Inc. Class stock announce a stock splitQuarterly Trade Review & Reliable Entry Point Alerts - newser.com
Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health - Finviz
Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY: DNA - Markets Financial Content
Frontier, Gevo (NASDAQ: GEVO) launch CO₂ rail network for ethanol plants in U.S. - Stock Titan
Is Ginkgo Bioworks Holdings Inc. Class stock a defensive play amid uncertaintyEarnings Trend Report & Verified Short-Term Trading Plans - newser.com
Why Investors Shouldn't Be Surprised By Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) 39% Share Price Plunge - simplywall.st
Ginkgo Bioworks Holdings (DNA) Price Target Decreased by 11.11% to 10.88 - Nasdaq
Using Python tools to backtest Ginkgo Bioworks Holdings Inc. strategiesLong Setup & Real-Time Chart Breakout Alerts - newser.com
Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):